
INTERNAL CONTROLS AND RISK
MANAGEMENT
The Board has established an ongoing process for
identifying, evaluating and managing risk on behalf
of the Group. The Board has carried out a robust
assessment of its principal and emerging risks and
the controls to help mitigate these. Further details
of the Group’s principal and emerging risks and
uncertainties can be found in the Strategic Report
on pages 58 to 62 and details of the Group’s internal
controls can be found on page 85. Details of the
Group’s hedging policies are set out in the Strategic
Report on page 49.
SHARE CAPITAL
As at 31 December 2022, the Company had
68,922,582 ordinary shares in issue, of which
4,712,985 ordinary shares were held by the
Company as treasury shares. (31 December 2021:
39,449,919 ordinary shares in issue, of which
4,190,178 were held in treasury).
Authority to allot shares
On 22 June 2022, at the Company’s last AGM, the
Board was granted authority to allot the Company’s
ordinary shares of £0.01 each or grant rights to
subscribe for, or convert any security into ordinary
shares in the Company up to an aggregate nominal
amount of £34,973.43 representing 3,497,343
ordinary shares. The Company was also granted
authority to issue a further 10 per cent of the issued
share capital to a total nominal amount of £34,973.43
in connection with a rights issue. Resolutions giving
authority to the directors to allot shares up to a
maximum nominal value of £69,946.86 (being
approximately 20 per cent of the then issued share
capital) as if statutory pre-emption rights did not
apply, were also approved. All authorities will expire
(unless previously renewed, varied or revoked) on the
conclusion of the 2023 AGM of the Company (or, if
earlier, at the close of business on 31 August 2023.)
The ordinary shares carry the right to receive
dividends and have one voting right per ordinary
share. There are no shares which carry specific
rights with regard to the control of the Company.
The shares are freely transferable. There are no
restrictions or agreements between shareholders on
the voting rights of any of the ordinary shares or the
transfer of shares.
The Company does not have a fixed life, and pursuant
to the Articles of Association, a continuation vote will
be put to shareholders every five years. The Directors
convened a General Meeting on 16 December
2019 at which a resolution for the continuation
of the Company was proposed and passed by
Shareholders.
Purchase of own shares
At the AGM held on 22 June 2022, the Directors
were granted the authority to purchase in the market
up to 5,242,517 ordinary shares representing 14.99
per cent of the ordinary shares at 10 May 2022, such
authority expiring at the conclusion of the 2023 AGM
of the Company (or, if earlier, until close of business
on 31 August 2023). The Company intends to seek
approval from the shareholders, by special resolution,
to renew this authority at the next AGM.
Further to the authority granted by shareholders at
the 2021 AGM, the Company commenced a share
buyback programme on 21 March 2022 to return
capital to shareholders, which was extended on the
29 April 2022 to the 30 June 2022. The Company
purchased 522,807 ordinary shares during 2022,
representing 0.76% of the issued capital as at 31
December 2022. The shares were repurchased for
£4,824,000 and are held in treasury. No further shares
have been purchased by the Company pursuant to
the buyback programme up to 22 March 2023 being
the latest practical date prior to the issue of this report.
Under Article 151 of the Company’s Articles of
Association, where in a financial period of the
Company ending on or after 31 December 2016 the
ordinary shares have traded, on average over that
financial period, at a discount in excess of 10 per cent
to net asset value per ordinary share, the Directors are
required to propose a special resolution at the next
AGM for the discontinuation of the business of the
Company in its present form. If such a discontinuation
resolution is passed, the Directors must, within
the next four months, put forward proposals to
shareholders to address the circumstances which
gave rise to the discontinuation resolution. Article 151
is a legacy of the Company’s constitution from when it
was trading as Honeycomb Investment Trust plc and
is reflective of the Company’s business structure at
that time.
Financial Statement 2022
POLLEN STREET
72